| Shane Cole, PT | |
|
555 Cornhusker Rd Ste 207, Bellevue, NE 68005-7918 | |
| (402) 614-4300 | |
| (402) 614-5211 |
| Full Name | Shane Cole |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 555 Cornhusker Rd Ste 207, Bellevue, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033775622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 3930 (Nebraska) | Secondary |
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Makovicka Harms Group Pc | 0143374124 | 49 |
News Archive
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) has approved LemtradaTM (alemtuzumab) for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.
The pandemic has made it more difficult for the 430,000+ Australians living with severe mental illnesses who are highly vulnerable to acute illness relapses when their habitual routines and standard health care arrangements are disrupted.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.
One year after The Centre for Drug Research and Development (CDRD) and the Neglected Global Diseases Initiative at the University of British Columbia (NGDI-UBC) came together to develop interventions for neglected global diseases, a project to combine existing approved drugs to better treat Tuberculosis (TB) has emerged as the collaboration's leading prospect.
› Verified 5 days ago
| Entity Name | Makovicka Harms Group Pc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1386879559 PECOS PAC ID: 0143374124 Enrollment ID: O20090811000488 |
News Archive
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) has approved LemtradaTM (alemtuzumab) for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.
The pandemic has made it more difficult for the 430,000+ Australians living with severe mental illnesses who are highly vulnerable to acute illness relapses when their habitual routines and standard health care arrangements are disrupted.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.
One year after The Centre for Drug Research and Development (CDRD) and the Neglected Global Diseases Initiative at the University of British Columbia (NGDI-UBC) came together to develop interventions for neglected global diseases, a project to combine existing approved drugs to better treat Tuberculosis (TB) has emerged as the collaboration's leading prospect.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shane Cole, PT Po Box 34699, Omaha, NE 68134-0699 Ph: (402) 932-6731 | Shane Cole, PT 555 Cornhusker Rd Ste 207, Bellevue, NE 68005-7918 Ph: (402) 614-4300 |
News Archive
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) has approved LemtradaTM (alemtuzumab) for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.
The pandemic has made it more difficult for the 430,000+ Australians living with severe mental illnesses who are highly vulnerable to acute illness relapses when their habitual routines and standard health care arrangements are disrupted.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.
One year after The Centre for Drug Research and Development (CDRD) and the Neglected Global Diseases Initiative at the University of British Columbia (NGDI-UBC) came together to develop interventions for neglected global diseases, a project to combine existing approved drugs to better treat Tuberculosis (TB) has emerged as the collaboration's leading prospect.
› Verified 5 days ago